Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TANSHINONE COMPOUND AND USE THEREOF FOR TREATING HEMANGIOMA
Document Type and Number:
WIPO Patent Application WO/2019/052477
Kind Code:
A1
Abstract:
Provided is the use of a class of tanshinone compounds for treating hemangioma; in particular, provided is the use of a class of compounds as shown in formula I below or a pharmaceutically acceptable salt thereof. The tanshinone compounds have a hemangioma cell inhibitory activity and can be used for preparing a pharmaceutical composition for treating hemangioma.

Inventors:
WU YEMING (CN)
YE YANG (CN)
WU ZHIXIANG (CN)
YAO SHENG (CN)
CAI YIHONG (CN)
TAN MINJIA (CN)
Application Number:
PCT/CN2018/105278
Publication Date:
March 21, 2019
Filing Date:
September 12, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE (CN)
SHANGHAI INST MATERIA MEDICA CAS (CN)
International Classes:
C07J73/00; A61K31/122; A61K31/343; A61P35/00; C07C50/16
Foreign References:
CN101412744A2009-04-22
CN101732294A2010-06-16
TW201021808A2010-06-16
CN103845314A2014-06-11
Other References:
TSAI, MINGYEN ET AL.: "Anti-Angiogenic Effect of Tanshinone Iia Involves Inhibition of Matrix Invasion and Modification of Mmp-2/Timp-2 Secretion in Vascular Endothelial Cells", CANCER LETTERS, vol. 310, no. 2, 28 November 2011 (2011-11-28), XP028266576, ISSN: 0304-3835, DOI: doi:10.1016/j.canlet.2011.06.031
Attorney, Agent or Firm:
XU AND PARTNERS, LLC. (CN)
Download PDF: